|
A Critical Role for Stat2 in Type 1 Intferon-Induced Apoptosis
|
5K22CA095326-02
|
$160,515
|
$160,515
|
GAMERO, ANA
|
TEMPLE UNIVERSITY
|
|
Activating robust immunity to tumor-associated antigens:mechanisms and biology
|
1R01CA138617-01
|
$311,250
|
$311,250
|
Janssen, Edith
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Antigen processing and HLA-peptide complexes in head and neck cancer
|
5R01CA110249-04
|
$320,085
|
$80,021
|
FERRONE, SOLDANO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,020,404
|
$202,040
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Antiviral Mechanisms of 2-5A Dependent RNase L
|
5R01CA044059-25
|
$367,548
|
$183,774
|
Silverman, Robert
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Bone Marrow Stem Cells: Novel Treatment of Human Glioma
|
5R01CA115729-04
|
$265,423
|
$132,712
|
LANG, FREDERICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support
|
3P30CA047904-21S2
|
$5,021,590
|
$188,812
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$735
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$590
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$846
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$68,965
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-26
|
$841,092
|
$8,411
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S2
|
$70,196
|
$597
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S3
|
$99,890
|
$849
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-20
|
$4,865,452
|
$41,356
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-25
|
$10,708,109
|
$107,081
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-14
|
$1,053,364
|
$10,534
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-20
|
$446,062
|
$4,461
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Central Illinois Community Clinical Oncology Program
|
5U10CA045807-24
|
$1,370,000
|
$13,700
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
|
5P01CA042063-24
|
$1,430,618
|
$71,531
|
Sharp, Phillip
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-22
|
$332,211
|
$3,322
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Columbus Community Clinical Oncology Program
|
5U10CA035261-26
|
$930,000
|
$9,300
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
Community Clinical Oncology Program
|
5U10CA035199-26
|
$424,645
|
$4,246
|
Grinblatt, David
|
NORTHSHORE UNIV HEALTHSYSTEM RES INST
|
|
Community Clinical Oncology Program
|
5U10CA035431-26
|
$1,889,840
|
$18,898
|
DAKHIL, SHAKER
|
VIA CHRISTI REGIONAL MEDICAL CENTER
|
|
Components of Translation in Signal Transduction
|
5R01CA092577-09
|
$288,915
|
$72,229
|
SCHIMMEL, PAUL
|
SCRIPPS RESEARCH INSTITUTE
|
|
Control of Cytokine Gene Expression in Lymphoid/Myeloid Cells
|
ZIA BC 009283
|
$607,726
|
$303,863
|
Young, Howard
|
CCR (NCI)
|
|
Control of Eye Melanoma Metastasis
|
5R01CA126447-07
|
$220,903
|
$55,226
|
Grossniklaus, Hans
|
EMORY UNIVERSITY
|
|
Cytokine Gene Therapy of Cancer - Preclinical Studies
|
5P01CA100327-05
|
$858,309
|
$102,997
|
Storkus, Walter
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-23
|
$1,282,700
|
$12,827
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Developing new immunotherapies based of CD4+ T cells
|
ZIA BC 011037
|
$647,010
|
$64,701
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Differentiation of Granulocytes and Macrophages
|
5R37CA022556-31
|
$230,408
|
$230,408
|
METCALF, DONALD
|
WALTER AND ELIZA HALL INST MEDICAL RES
|
|
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
|
5R01CA129350-02
|
$546,210
|
$546,210
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-26
|
$747,046
|
$7,470
|
Nikcevich, Daniel
|
DULUTH CLINIC, LTD.
|
|
Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance
|
5R01CA138234-02
|
$513,998
|
$128,500
|
Michor, Franziska
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$7,852
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group
|
5U10CA027525-31
|
$453,259
|
$27,196
|
GOLDSTEIN, LORI
|
FOX CHASE CANCER CENTER
|
|
Eastern Cooperative Oncology Group
|
5U10CA049883-21
|
$330,145
|
$19,809
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Eastern Cooperative Oncology Group
|
5U10CA016116-36
|
$284,348
|
$17,061
|
FORASTIERE, ARLENE
|
JOHNS HOPKINS UNIVERSITY
|
|
Eastern Cooperative Oncology Group
|
5U10CA013650-37
|
$231,854
|
$13,911
|
HABERMANN, THOMAS
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA015488-37
|
$416,475
|
$24,989
|
HALLER, DANIEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Eastern Cooperative Oncology Group
|
5U10CA049957-21
|
$362,155
|
$21,729
|
JOHNSON, DAVID
|
VANDERBILT UNIVERSITY
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-35
|
$159,358
|
$9,561
|
sparano, joseph
|
YESHIVA UNIVERSITY
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
|
5U10CA021076-34
|
$620,983
|
$37,259
|
Kahl, Brad
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Eastern Cooperative Oncology Group Chair's Office
|
5U10CA086802-11
|
$655,420
|
$39,325
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-34
|
$460,085
|
$27,605
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
|
5U10CA021115-35
|
$9,256,982
|
$555,419
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
$25,042
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Eastern Cooporative Oncology Group (Main Institution)
|
5U10CA039229-24
|
$250,100
|
$15,006
|
KIRKWOOD, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
ECM-Mediated Apoptosis in p53 (-) HMECs
|
5R01CA088799-09
|
$222,477
|
$111,239
|
SEEWALDT, VICTORIA
|
DUKE UNIVERSITY
|
|
ECOG CCOP Research Base
|
5U10CA037403-24
|
$2,330,240
|
$69,907
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
Total relevant funding to Interferon for this search: $15,096,924
|